Loading...
•
Dec 31, 2024
LifeStance Q4 2024 Earnings Report
LifeStance reported fourth quarter and full year results, demonstrating revenue growth and improved profitability.
Key Takeaways
LifeStance Health Group reported a 16% increase in fourth-quarter revenue, reaching $325.5 million. The company's clinician base grew by 12% to 7,424, with visit volumes increasing by 14% to 2.0 million. Net loss for the quarter was $7.1 million, while net cash from operations was $62.3 million. Adjusted EBITDA stood at $32.8 million, and free cash flow was $56.0 million.
Fourth quarter revenue increased by 16% to $325.5 million.
Clinician base grew by 12% to 7,424 clinicians.
Visit volumes for the fourth quarter increased by 14% to 2.0 million.
Net loss for the fourth quarter was $7.1 million.
Forward Guidance
LifeStance expects full year 2025 revenue of $1.40 billion to $1.44 billion, Center Margin of $440 million to $464 million, and Adjusted EBITDA of $130 million to $150 million.
Positive Outlook
- Expecting full year 2025 revenue of $1.40 billion to $1.44 billion.
- Center Margin of $440 million to $464 million.
- Adjusted EBITDA of $130 million to $150 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...